Radiation therapy for breast cancer patients over 70
Part of Cancer, Skin clinical trials.
This trial tests a precise type of radiation called SBRT for breast cancer in patients aged 70 or older who cannot have surgery or choose not to. The goal is to see if this treatment can effectively control the tumor without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older
- You have been diagnosed with breast cancer (any time in the past)
- Doctors have decided you cannot have surgery, or you choose not to have surgery
- The tumor can be seen on a scan like an ultrasound, CT, or MRI
- You have not had surgery or radiation for this current breast cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses individual measures of how sensitive your body’s tissues are to radiation to guide after-surgery breast radiation treatment. It aims to keep treatment safe and effective while tailoring the plan to each person.
This trial is testing a new treatment approach for patients with a certain type of breast cancer (HR+/HER2-). It combines radiation therapy with chemotherapy and an immunotherapy drug before the patient's main surgery, to see if it can shrink or eliminate the tumor more effectively.
This trial tests a precise type of radiation (SABR) for breast cancer that has spread to other parts of the body. It aims to see if adding SABR to your regular systemic therapy can help control the tumor in the breast and improve your quality of life.
This trial tests a new type of radiation therapy (DaRT) that uses tiny, implantable seeds to deliver targeted alpha radiation to breast tumors. It is designed for older patients (65+) or those who are too frail for surgery, offering a less invasive option for controlling the cancer.
This study looks at a brief type of radiation called SBRT given soon after starting hormone therapy for certain early breast cancers in women age 75 and older. It may help treat the cancer locally while aiming to be easier to receive than longer radiation schedules.
This trial tests a precise, high-dose radiation treatment (called SABR) for older women with early-stage breast cancer who choose not to have surgery. It aims to control the tumor with fewer side effects and may be an option if you have a small, ER+, HER2- tumor that hasn't spread to lymph nodes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.